<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04729465</url>
  </required_header>
  <id_info>
    <org_study_id>10/01/2020-5208</org_study_id>
    <nct_id>NCT04729465</nct_id>
  </id_info>
  <brief_title>The Effect of BIS-guided Propofol Induction on Hemodynamic Response in Patients With Cardiac Risk.</brief_title>
  <official_title>The Effect of BIS-guided Propofol Induction on the Peroperative and Postoperative Hemodynamic Response in Patients With Cardiac Risk in Ear-nose-throat Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University-Cerrahpasa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University-Cerrahpasa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anesthesia induction will be started by monitoring ECG, non-invasive artery monitoring,&#xD;
      peripheral oxygen saturation and BIS for all patients who are taken to the operating room&#xD;
      without sedation. The patients were divided into 2 groups: Group P; Propofol 2 mg / kg bolus&#xD;
      (in 10 seconds), Group B; Propofol will be started as an infusion dose of 0,25 mg / kg / min&#xD;
      and will be discontinued when the BIS reaches a minimum value of 60. Noninvasive arterial&#xD;
      blood pressure and heart rate will be measured at 2-minute intervals during the first 10&#xD;
      minutes of induction and then at 15th , 20th ,30th and 60th minutes peroperatively.&#xD;
      Hypotension; mean arterial pressure (MAP) &lt;60 mmHg, bradycardia heart rate &lt;60 / min,&#xD;
      hypertension MAP&gt; 120 mmHg and tachycardia heart rate&gt; 100 / min were defined. The difference&#xD;
      of changes, their duration, the difference between the maximal value and the baseline value,&#xD;
      and the number of occurrences of hypotension, hypertension, and arrhythmias during the entire&#xD;
      induction and perioperative period will be recorded. Noninvasive arterial blood pressure and&#xD;
      heart rate measurements of the patients will be made in the postoperative period at 5th ,&#xD;
      15th , 30th minutes and at 1st , 2nd , 4th , and 24th hours. At the end of the 1st month, it&#xD;
      will be questioned whether the patients encounter a cardiovascular problem that will require&#xD;
      treatment or hospitalization in the period following the surgery. All patients will be&#xD;
      started with 5 ml / kg / hour IV crystalloid infusion. When the MAP falls below 60 mmHg&#xD;
      during induction, the patient will be given the Trendelenburg position and the crystalloid&#xD;
      infusion will be increased to 10 ml / kg / hour, and vasoconstrictor drug will be added if&#xD;
      the hypotension does not improve within the following 10 minutes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      surgeries performed on patients participating in the study&#xD;
&#xD;
      minor elective ear nose throat surgery (microlaryngeal surgery, biyopsy for ENT malignancy,&#xD;
      myringoplasty)&#xD;
&#xD;
      exclusion criteria;history of stroke, stupor, dementia, long-term use of central nervous&#xD;
      system (CNS) activator drugs, benzodiazepines and/or opiates therapy, and pregnant females&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 8, 2021</start_date>
  <completion_date type="Anticipated">August 10, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Drug: Propofol Device : Bispectral Index Monitor</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Participant</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Propofol consumption</measure>
    <time_frame>30 minutes-2 hours</time_frame>
    <description>amount of Propofol consumption during the induction of anesthesia and perioperative period with or without BIS monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamic alterations</measure>
    <time_frame>30 minutes- 2 hours</time_frame>
    <description>to observe hemodynamic alterations during propofol induction with or without BIS monitoring .</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Anesthesia, General</condition>
  <arm_group>
    <arm_group_label>Active Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active Comparator: Control Patients with cardiac disaese receive general anesthesia with Propofol&#xD;
Interventions:&#xD;
Drug: Propofol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental: Bispectral Index Monitor Patients with cardiac disease receive a general anesthesia with Propofol where the amount of anesthetics administered is decided taking into consideration the Bispectral Index Monitor.&#xD;
Interventions:&#xD;
Drug: Propofol Device: Bispectral Index Monitor</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol</description>
    <arm_group_label>Active Comparator</arm_group_label>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bispectral Index Monitor</intervention_name>
    <description>Bispectral Index Monitor</description>
    <arm_group_label>Experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        The patients with a cardiovascular problem requiring ENT surgery lasting less than 2 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients having history of stroke, stupor, dementia, long-term use of central nervous&#xD;
        system (CNS) activator drugs, benzodiazepines and/or opiates therapy, and pregnant females&#xD;
        were excluded from the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>January 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2021</study_first_posted>
  <last_update_submitted>January 30, 2021</last_update_submitted>
  <last_update_submitted_qc>January 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University-Cerrahpasa</investigator_affiliation>
    <investigator_full_name>Fatih YÄ±lmazer</investigator_full_name>
    <investigator_title>Department of Anesthesiology, Resident, MD.</investigator_title>
  </responsible_party>
  <keyword>BIS, propofol, anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

